Home/Filings/4/A/0001567619-22-020920
4/A//SEC Filing

Oki Mark K 4/A

Accession 0001567619-22-020920

CIK 0001385818other

Filed

Nov 27, 7:00 PM ET

Accepted

Nov 28, 4:30 PM ET

Size

4.8 KB

Accession

0001567619-22-020920

Insider Transaction Report

Form 4/AAmended
Period: 2022-11-18
Oki Mark K
Chief Financial Officer
Transactions
  • Purchase

    Common Shares

    2022-11-18$0.23/sh+90,000$20,700190,000 total

Documents

1 file

Issuer

AYTU BIOPHARMA, INC

CIK 0001385818

Entity typeother

Related Parties

1
  • filerCIK 0001491847

Filing Metadata

Form type
4/A
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 4:30 PM ET
Size
4.8 KB